These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 21118696)

  • 1. Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.
    Jensen BC; O'Connell TD; Simpson PC
    J Mol Cell Cardiol; 2011 Oct; 51(4):518-28. PubMed ID: 21118696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases.
    Zhang J; Simpson PC; Jensen BC
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H725-H733. PubMed ID: 33275531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α
    Cowley PM; Wang G; Joshi S; Swigart PM; Lovett DH; Simpson PC; Baker AJ
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1109-H1118. PubMed ID: 28822963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.
    Jensen BC; OʼConnell TD; Simpson PC
    J Cardiovasc Pharmacol; 2014 Apr; 63(4):291-301. PubMed ID: 24145181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice.
    Montgomery MD; Chan T; Swigart PM; Myagmar BE; Dash R; Simpson PC
    PLoS One; 2017; 12(1):e0168409. PubMed ID: 28081170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.
    Perez DM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The α1A-adrenergic receptor subtype mediates increased contraction of failing right ventricular myocardium.
    Cowley PM; Wang G; Chang AN; Makwana O; Swigart PM; Lovett DH; Stull JT; Simpson PC; Baker AJ
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H888-96. PubMed ID: 26116709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Β-arrestin: a signaling molecule and potential therapeutic target for heart failure.
    Noor N; Patel CB; Rockman HA
    J Mol Cell Cardiol; 2011 Oct; 51(4):534-41. PubMed ID: 21074538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.
    Iwata M; Cowling RT; Yeo SJ; Greenberg B
    J Mol Cell Cardiol; 2011 Oct; 51(4):542-7. PubMed ID: 21147120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling.
    Akhter SA; Milano CA; Shotwell KF; Cho MC; Rockman HA; Lefkowitz RJ; Koch WJ
    J Biol Chem; 1997 Aug; 272(34):21253-9. PubMed ID: 9261135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alpha1-adrenergic receptors in cardiac pathophysiology.
    Shannon R; Chaudhry M
    Am Heart J; 2006 Nov; 152(5):842-50. PubMed ID: 17070143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.
    Ruffolo RR; Kopia GA
    Am J Med; 1986 Feb; 80(2B):67-72. PubMed ID: 2868661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. {alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium.
    Jensen BC; Swigart PM; De Marco T; Hoopes C; Simpson PC
    Circ Heart Fail; 2009 Nov; 2(6):654-63. PubMed ID: 19919991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs.
    Autelitano DJ; Woodcock EA
    J Mol Cell Cardiol; 1998 Aug; 30(8):1515-23. PubMed ID: 9737938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart.
    McKinsey TA
    J Mol Cell Cardiol; 2011 Oct; 51(4):491-6. PubMed ID: 21108947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries.
    Jensen BC; Swigart PM; Laden ME; DeMarco T; Hoopes C; Simpson PC
    J Am Coll Cardiol; 2009 Sep; 54(13):1137-45. PubMed ID: 19761933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C.
    Rokosh DG; Stewart AF; Chang KC; Bailey BA; Karliner JS; Camacho SA; Long CS; Simpson PC
    J Biol Chem; 1996 Mar; 271(10):5839-43. PubMed ID: 8621454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β₂ AR agonists in treatment of chronic heart failure: long path to translation.
    Talan MI; Ahmet I; Xiao RP; Lakatta EG
    J Mol Cell Cardiol; 2011 Oct; 51(4):529-33. PubMed ID: 20888833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of alpha1-adrenergic signaling.
    Debrus S; Rahbani L; Marttila M; Delorme B; Paradis P; Nemer M
    Mol Cell Biol; 2005 Oct; 25(19):8669-82. PubMed ID: 16166646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PGC-1 cascade as a therapeutic target for heart failure.
    Schilling J; Kelly DP
    J Mol Cell Cardiol; 2011 Oct; 51(4):578-83. PubMed ID: 20888832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.